Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Stupp

Showing results (201-210 of 314) with videos related to

Pageof 32
Sort By:
Journal of Neuro-Oncology|January 21, 2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progressionGünter Eisele, Antje Wick, Anna-Carina Eisele, et al.
The Lancet. Oncology|August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaMichael Weller, Martin van den Bent, Kirsten Hopkins, et al.
Neuro-Oncology|September 7, 2018
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesAlireza Mansouri, Laureen D Hachem, Sheila Mansouri, et al.
Journal of Translational Medicine|January 9, 2013
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion proteinJulien Laurent, Cedric Touvrey, Silke Gillessen, et al.
The Journal of Clinical Investigation|June 2, 2026
The Peri-necrotic Niche of Glioblastoma Drives Tumor-associated Macrophage Polarization and Immunosuppression via Podoplanin-mediated CLEC5A ActivationJiabo Li, Xuya Wang, Luqing Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group StudyEric Raymond, Alba A Brandes, Christian Dittrich, et al.
JAMA Network Open|November 25, 2025
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed GlioblastomaEmilie Le Rhun, Debaleena Sain, Sara C Erridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Cancers|November 26, 2022
Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived XenograftsMatthew McCord, Elizabeth Bartom, Kirsten Burdett, et al.
Pageof 32

Showing results (201-210 of 314) with videos related to

Sort By:
Pageof 32
Journal of Neuro-Oncology|January 21, 2014
Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progressionGünter Eisele, Antje Wick, Anna-Carina Eisele, et al.
The Lancet. Oncology|August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastomaMichael Weller, Martin van den Bent, Kirsten Hopkins, et al.
Neuro-Oncology|September 7, 2018
MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challengesAlireza Mansouri, Laureen D Hachem, Sheila Mansouri, et al.
Journal of Translational Medicine|January 9, 2013
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion proteinJulien Laurent, Cedric Touvrey, Silke Gillessen, et al.
The Journal of Clinical Investigation|June 2, 2026
The Peri-necrotic Niche of Glioblastoma Drives Tumor-associated Macrophage Polarization and Immunosuppression via Podoplanin-mediated CLEC5A ActivationJiabo Li, Xuya Wang, Luqing Tong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed GlioblastomaCaroline Happold, Thierry Gorlia, Olivier Chinot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group StudyEric Raymond, Alba A Brandes, Christian Dittrich, et al.
JAMA Network Open|November 25, 2025
Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed GlioblastomaEmilie Le Rhun, Debaleena Sain, Sara C Erridge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Reply to F. Felix et al and M.F. Fay et alCaroline Happold, Thierry Gorlia, Oliver Chinot, et al.
Cancers|November 26, 2022
Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived XenograftsMatthew McCord, Elizabeth Bartom, Kirsten Burdett, et al.
Pageof 32